Grove Collaborative: From Platform Turmoil to a Health-Centric Pivot

After a painful period of e-commerce platform migration and deliberately reduced advertising, Grove Collaborative is showing signs of inflection. In the second quarter of 2026, net revenue ticked up 1% sequentially to $36.6 million, adjusted EBITDA turned positive for a third consecutive quarter, and operating cash flow came in at $1.3 million. Management framed the quarter as “consistent with the outlook we provided last quarter” — Tom Siragusa, Chief Financial Officer · 2026-08-06 (Tom Siragusa). The year-over-year decline was attributed to a smaller active customer base and lingering platform disruptions, but revenue per order grew 6% year over year, and unit economics continue to improve. The company is beginning to reinvest in advertising after a long pullback, with spend inching up from 3.2% to 3.4% of revenue.

Prior quarters laid the groundwork. In the Q1 2026 call, management touted the success of the new Green Rewards loyalty program, noting it “has improved our underlying gross margin structure” — Jeff Yurcisin, Chief Executive Officer · 2026-05-08 (Jeff Yurcisin). In the Q4 2025 call, the CFO mentioned a reduction in force that “reset our cost base lower” — Tom Siragusa, Chief Financial Officer · 2026-03-05 (Tom Siragusa). These steps are now yielding the operating leverage visible in the latest results.

The Pivot to Human Health

Perhaps the most striking shift is the company's explicit embrace of human health as its core mission. Jeff Yurcisin described the problem Grove solves:

A dish soap, a lotion, a cleaning spray with synthetic chemicals, or microplastics. Is a small exposure on its own. A vitamin or supplement with unverified sourcing carries the same kind of risk. that is the problem Grove exists to solve.

Expansion Beyond the Core

Grove is also broadening its channel and category footprint. It recently launched drop-ship capabilities, allowing it “to further expand selection into new categories without the inventory ownership cost of traditional vendor relationships” — Jeff Yurcisin, Chief Executive Officer · 2026-08-06. The initial brands are in, and plans include larger formats like mattresses and air filtration. This builds on category expansion work and the launch of an updated subscription experience, which is now present in more than 80% of orders. The company is also expanding onto Amazon and QVC, a move it believes is additive rather than cannibalistic. These initiatives are all directed at customer experience improvements, which management argues will support more full-funnel customer acquisition in the back half of 2026.

Financial Position and Outlook

The balance sheet remains fragile but stable. Cash and restricted cash rose to $11.4 million from $10.4 million in Q1, and the company reaffirmed full-year revenue guidance of $142.5–152.5 million and adjusted EBITDA at breakeven to positive low single digits. Total revenue is still down significantly from its peak, but management expects sequential revenue improvement in each remaining quarter.

Total revenue has fallen to $36 million (Q1 2026) from $99 million in Q2 2021, a 58% decline. Yet gross margin has expanded to approximately 55%, up from 50% in 2021, reflecting the shift toward higher-margin categories and a more disciplined promotional posture.

The departure of CFO Tom Siragusa adds a note of uncertainty, but the search for his successor is underway.

In sum, Grove is executing a deliberate turnaround: stabilizing the base, pivoting to human health, and expanding into new channels. The stock remains deeply undervalued by the market, but the operational metrics are finally moving in the right direction.